Are you interested to hear how reforming pharmaceutical care and pharmaceutical financing as well as guidance and evaluation have started to be implemented both nationally
Janne Martikainen (ESiOR Oy) discusses the topic on MTV3’s Huomenta Suomi program In the interview, the treatment and prevention of cardiovascular diseases and the financial
Pharmaceutical work provided by Finnish community pharmacies save wellbeing service counties about 855 million euros in health services per year In an evaluation we conducted
Assessment: Self-care counselling carried out by the Finnish community pharmacies provides wellbeing service counties with more than half a billion euros of savings In an
The link between the risk of myocardial infarction recurrence and the costs of health and social services has been demonstrated in a study conducted in
The value of one drug trial for healthcare is up to EUR 10 million According to a study we at ESiOR carried out together with
Chairing education related to artificial intelligence (AI) for real-world evidence (RWE) at AI x Pharma x Health 2024: “Explore the potential of artificial intelligence in
Multiple new ESiOR innovations are presented during the International Society for Pharmacoeconomics and Outcomes Research (ISPOR US) main congress at Atlanta in the Unites States
The GenomiTerveys project, led by the Helsinki Biobank, has received the first-ever Biobank Research of the Year award from the Finnish Biobank Cooperative – FINBB.
In cooperation with Business Finland and the Fingenious Ecosystem, ESiOR will be part of the trade mission to Denmark on 27-28 November. After this, we
ISPOR is the biggest conference of Health Economics and Pharmacoeconomics. This year the European conference will take place in Copenhagen, Denmark on 12-15 November. The
